Individual investor using custom Wealth-Lab Developer chart scripts to detect stock reversals and filtering on fundamentals using AAII's Stock Investor Pro database.
Leerink Partners reiterates its outperform rating for AMAG. "there is a high likelihood that the [competitor's] drug is contraindicated for use in pregnant women". [Street Insider]
No comments:
Post a Comment